| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | John F. Dillon | Q38545342 |
| Paul Brennan | Q91615677 | ||
| P2093 | author name string | Jacob George | |
| Kathleen Clare | |||
| P2860 | cites work | Molecular physiology of urate transport | Q24298185 |
| Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol | Q24652967 | ||
| Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging | Q27006131 | ||
| Nonalcoholic fatty liver disease: a systematic review | Q28263139 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity | Q29614932 | ||
| Inflammasomes in health and disease | Q29616356 | ||
| Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation | Q34550052 | ||
| EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease | Q34676840 | ||
| Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome | Q34718837 | ||
| NLRP3 inflammasome activation is required for fibrosis development in NAFLD. | Q35146713 | ||
| Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: a large population-based study. | Q36153675 | ||
| Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver. | Q36418940 | ||
| Serum uric acid is independently and linearly associated with risk of nonalcoholic fatty liver disease in obese Chinese adults | Q37479795 | ||
| Endoplasmic reticulum stress in nonalcoholic fatty liver disease | Q38027194 | ||
| Xanthine oxidase: biochemistry, distribution and physiology | Q39742549 | ||
| Prevalence and Severity of Nonalcoholic Fatty Liver Disease in Non-Obese Patients: A Population Study Using Proton-Magnetic Resonance Spectroscopy. | Q41543136 | ||
| Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults | Q42577349 | ||
| Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress | Q42829265 | ||
| The significance of serum xanthine oxidoreductase in patients with nonalcoholic fatty liver disease. | Q43720557 | ||
| Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. | Q45124709 | ||
| Nonalcoholic fatty liver disease in lean individuals in the United States | Q45892282 | ||
| Uric acid regulates hepatic steatosis and insulin resistance through the NLRP3 inflammasome-dependent mechanism | Q46627915 | ||
| Advanced glycation end products promote hepatosteatosis by interfering with SCAP-SREBP pathway in fructose-drinking mice | Q47979773 | ||
| Serum uric acid levels predict incident nonalcoholic fatty liver disease in healthy Korean men. | Q51152441 | ||
| The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model. | Q52941618 | ||
| Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes. | Q53028338 | ||
| The prevalence of nonalcoholic fatty liver disease and relationship with serum uric acid level in Uyghur population. | Q55620377 | ||
| Increased Serum Uric Acid over five years is a Risk Factor for Developing Fatty Liver | Q58799660 | ||
| Studies on the oxidative half-reaction of xanthine oxidase | Q71855295 | ||
| How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? | Q80470863 | ||
| Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds | Q86604185 | ||
| Uric acid induced hepatocytes lipid accumulation through regulation of miR-149-5p/FGF21 axis | Q89763311 | ||
| Relationship Between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients | Q90164330 | ||
| Health benefits of Mediterranean diet in nonalcoholic fatty liver disease | Q90397066 | ||
| Development and validation of diagnostic triage criteria for liver disease from a minimum data set enabling the 'intelligent LFT' pathway for the automated assessment of deranged liver enzymes | Q90478179 | ||
| Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-obese and lean population of living liver donors: The impact of uric acid | Q90699949 | ||
| Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup | Q91977906 | ||
| A Simple Index for Nonalcoholic Steatohepatitis-HUFA-Based on Routinely Performed Blood Tests | Q92519858 | ||
| Xanthine oxidase inhibition attenuates insulin resistance and diet-induced steatohepatitis in mice | Q92825068 | ||
| Efficacy of a non-invasive model in predicting the cardiovascular morbidity and histological severity in non-alcoholic fatty liver disease | Q92995492 | ||
| Predictive Values of Serum Uric Acid and Alanine-aminotransferase for Fatty Liver Index in Montenegrin Population | Q93185871 | ||
| P433 | issue | 15 | |
| P921 | main subject | non-alcoholic steatohepatitis | Q28692677 |
| P304 | page(s) | 1683-1690 | |
| P577 | publication date | 2020-04-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review | |
| P478 | volume | 26 |
Search more.